Source comparison
Tesamorelin vs. CJC-1295: A Quick Comparison for Researchers
While both are GHRH analogues, they aren't identical. Understanding their subtle differences is key for any researcher designing a study. We've put together a simple table to highlight the key distinctions we've observed. Structure 44 amino acid chain (full GH
This comparison does not assign a generated winner or score.
- While both are GHRH analogues, they aren't identical. Understanding their subtle differences is key for any researcher designing a study. We've put together a simple table to highlight the key distinctions we've observed.
- Structure
- 44 amino acid chain (full GHRH) with modification
- 29 amino acid chain (truncated GHRH) with modifications
- Tesamorelin is the full-length hormone, which may have subtly different downstream effects compared to the truncated form.
- Half-Life
- ~25-40 minutes
- ~30 minutes
- Both are suited for pulsatile dosing strategies, mimicking the body's natural rhythm. This is a key advantage.
- Primary Research Focus
- Visceral Adipose Tissue (VAT) reduction
- General GH elevation, anti-aging, recovery
- While both increase GH, Tesamorelin has a more established research profile specifically for visceral fat.
- Mechanism
- Binds to GHRH receptors to stimulate GH release
- The core mechanism is identical, but the different structures could lead to slight variations in receptor affinity and cellular response.